http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2008361734-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79b1d2f692ed31f7a62ad4fde55d6e82
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5153
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709
filingDate 2008-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_908c12364a42cb8d459aba496c3d3d49
publicationDate 2010-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AU-2008361734-A1
titleOfInvention Poly DL-lactide-co-glycolide (PLG) nanoparticle based oral delivery system for Econazole moxifloxacin and refampicin
priorityDate 2008-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135900090
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152946
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743192
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523438
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410031093
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503137
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502593
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8027
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502530
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14052
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3198
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431847471

Total number of triples: 26.